Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,306 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07057765Recruiting
Blood markers for predicting DLBCL treatment response
This study looks at how certain blood tests (like CRP, albumin, and their ratios) might help predict how well treatment works for newly diagnosed DLBCL. If you are getting R-CHOP, this trial could help doctors better understand your response to therapy.
Cairo, Cairo GovernorateAges 18–65 - NCT06218030RecruitingPhase 4
L-methylfolate for treatment-resistant anxiety
This study tests whether adding L-methylfolate (a form of vitamin B9) to your current antidepressant can help with generalized anxiety disorder that has not responded to other treatments. It is for adults who are already on a stable dose of an SSRI or SNRI medication.
Kingston, OntarioAges 18–65 - NCT06231264Recruiting
Electrical acupressure for mild to moderate colitis
This trial tests whether a gentle electrical stimulation device (like acupuncture without needles) on the skin can help people with mild to moderate ulcerative colitis who haven't gotten better with standard treatments.
Xi'an, ShaanxiAges 18 years+ - NCT05369351RecruitingPhase 2
Mirabegron for brain bleeding soon after symptoms start
This trial studies whether mirabegron can improve safety and outcomes after an intracerebral hemorrhage (a type of brain bleeding). Participants start treatment within 72 hours of symptom onset and are monitored for recovery and side effects.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07048496Recruiting
At-home BCG treatment for bladder cancer with support
This study is testing a way for people with early-stage bladder cancer to receive their BCG treatment at home, with extra support. It aims to see if doing treatment at home is safe and helpful for patients.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07051850Recruiting
Quality of life study for relapsed myeloma immunotherapy
This study compares quality of life and treatment results in people with relapsed or refractory multiple myeloma who receive either newer or standard immunotherapy. It aims to understand how these treatments affect daily living and outcomes.
Seocho, SeoulAges 19 years+ - NCT07046650RecruitingPhase 2
Cisplatin plus gemcitabine for rare tumors after PD-1 therapy
This trial tests a combination of two chemotherapy drugs, cisplatin and gemcitabine, for people with certain rare cancers that no longer respond to a type of immunotherapy called PD-1 inhibitors. The goal is to see how well this treatment works and what side effects it may cause.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07052474Recruiting
Intensive trauma therapy for teens with PTSD
This study tests a short, intensive trauma-focused treatment for teenagers aged 13 to 17 with PTSD. It aims to see if the program is practical and helpful for teens and their families.
StockholmAges 13–17 - NCT07037264Enrolling by invitation
Laser treatment for thyroid surgery scars
This study tests if a special laser can improve scars from thyroid surgery. It is for people with fresh or older scars in the middle of the neck.
Beijing, Beijing MunicipalityAges 18–70 - NCT07041359RecruitingPhase 4
Traditional Chinese medicine for elderly heart disease patients with ongoing symptoms
This trial tests whether traditional Chinese medicine can help elderly patients with coronary heart disease who still have chest pain or discomfort despite standard treatments. It focuses on those who cannot have or have not fully benefited from procedures like stents or bypass surgery.
Beijing, Beijing MunicipalityAges 75–90 - NCT07041424Enrolling by invitation
Bonding methods for filling cavities to reduce tooth sensitivity
This trial tests two ways of bonding a tooth-colored filling to see which reduces tooth sensitivity after the procedure. It may help if you have a moderate cavity on a back tooth that causes brief pain or sensitivity.
Islamabad, FederalAges 18 years+ - NCT07043686Recruiting
Cerebrolysin for early stroke recovery
This trial tests if adding Cerebrolysin to standard rehabilitation helps people recover arm and hand function better after a first-time, moderate stroke. You may be eligible if you had a stroke and can follow simple instructions.
LjubljanaAges 18 years+ - NCT07037472Recruiting
Imaging calcium deposits in dermatomyositis patients
This study uses a special imaging technique (photoacoustic/ultrasound) to look at calcium deposits under the skin in people with dermatomyositis. It aims to find patterns that help doctors understand the condition and track how well treatments work.
BeijingAges 18–80 - NCT07039747RecruitingPhase 2
Can a dietary supplement help people with irritable bowel syndrome?
This trial is testing if a dietary supplement can reduce symptoms of irritable bowel syndrome (IBS). You might qualify if you have been diagnosed with IBS, have moderate to severe symptoms, and are between 18 and 75 years old.
Rouen, FranceAges 18–75 - NCT07041450Recruiting
Screening for Alzheimer's treatment using digital tests and blood tests
This study is testing whether simple digital memory tests and blood tests can help find people who might qualify for anti-amyloid treatments (medications that target Alzheimer's-related proteins). It aims to make screening easier and faster, without needing a spinal tap or PET scan.
Greenfield Park, QuebecAges 55–90 - NCT07024667Recruiting
Laser treatment study for vaginal atrophy symptoms
This trial tests a carbon dioxide laser (FemiLift) to see if it can help women with vaginal dryness, burning, itching, or pain during sex caused by menopause. It aims to improve symptoms without hormones.
HaderaAges 45–75 - NCT07033416Recruiting
Training to reduce cocaine cravings
This trial tests a computer training program that helps people with cocaine use disorder change their automatic reactions to drug cues. The goal is to see if this training can reduce cravings and improve treatment outcomes.
Milan, MilanoAges 18 years+ - NCT07033819RecruitingPhase 2
Fuzuloparib and apatinib before surgery for ovarian cancer
This trial tests a combination of two oral drugs—fuzuloparib (a PARP inhibitor) and apatinib (which blocks blood vessel growth to tumors)—given before surgery for advanced ovarian cancer that cannot be removed right away. It is for people whose tumors have a specific genetic marker (HRD positive) and who have not had prior cancer treatment.
Beijing, Beijing MunicipalityAges 18–70 - NCT07023952Recruiting
Phenol plus laser for pilonidal sinus healing study
This trial tests if adding phenol treatment to laser therapy helps the wound heal faster and better after treating pilonidal sinus (a small tunnel in the skin near the tailbone). It is for people who have this condition for the first time and have only a few sinus openings.
Istanbul, OtherAges 18 years+ - NCT07032363Recruiting
Depression and HIV treatment support study
This study tests a program that helps people with HIV manage depression and stick to their treatment. It's for adults in Cape Town, South Africa, who have a detectable HIV viral load or may have one, and who show signs of depression.
Cape TownAges 18 years+ - NCT07025434Recruiting
Hip Bump Manipulation vs Sham in Healthy Adults
This study tests a hip adjustment technique (called hip bump manipulation) to see how it affects joint movement and muscles in healthy adults. If you join, you will receive either the real manipulation or a fake (sham) treatment, so researchers can compare the two.
Orangeburg, New YorkAges 18–45 - NCT07027930Recruiting
EMDR group therapy for traffic accident trauma
This study tests a type of therapy called EMDR (which uses eye movements to help process trauma) in a group setting for people who are still struggling with stress symptoms from a past road traffic accident. It aims to see if this approach is helpful and practical.
Lahore, Punjab ProvinceAges 18–45 - NCT05838066RecruitingPhase 3
KN026 plus HB1801 for HER2-positive advanced breast cancer
This Phase 3 study tests whether taking KN026 with HB1801 as first treatment works better and is safe for people with HER2-positive breast cancer that has come back or spread. It may help by improving tumor response and delaying progression compared with the study’s treatment plan.
Beijing, chaoyangAges 18 years+ - NCT07015073Recruiting
Comparing laser combinations for port-wine stains
This trial tests whether using two different lasers one after the other works better than a single laser for treating port-wine stains (a type of birthmark). The goal is to see if the combination treatment can improve appearance with fewer sessions.
Madrid, SpainAges 18 years+
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,306 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.